{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T04:24:36Z","timestamp":1720412676833},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.pnpbp.2017.02.021","type":"journal-article","created":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T12:30:49Z","timestamp":1488371449000},"page":"80-87","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Influence of single-dose quetiapine on fear network activity \u2013 A pharmaco-imaging study"],"prefix":"10.1016","volume":"76","author":[{"given":"J.","family":"Diemer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Zwanzger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Fohrbeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Zavorotnyy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Notzon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Silling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Arolt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Domschke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Pfleiderer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2017.02.021_bb0005","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/YIC.0000000000000127","article-title":"Role and clinical implications of atypical antipsychotics in anxiety disorders, obsessive-compulsive disorder, trauma-related, and somatic symptom disorders: a systematized review","volume":"31","author":"Albert","year":"2016","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.pnpbp.2017.02.021_bb0010","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1080\/15622970802465807","article-title":"World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision","volume":"9","author":"Bandelow","year":"2008","journal-title":"World. J. Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2017.02.021_bb0015","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1017\/S1461145709990423","article-title":"Extended-release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled study","volume":"13","author":"Bandelow","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2017.02.021_bb0020","series-title":"Anxiety and its Disorders: the Nature and Treatment of Anxiety and Panic","author":"Barlow","year":"2002"},{"issue":"6","key":"10.1016\/j.pnpbp.2017.02.021_bb0025","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1037\/0022-006X.56.6.893","article-title":"An inventory for measuring clinical anxiety: psychometric properties","volume":"56","author":"Beck","year":"1988","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.pnpbp.2017.02.021_bb0030","series-title":"Kompendium der Psychiatrischen Pharmakotherapie","author":"Benkert","year":"2010"},{"issue":"12","key":"10.1016\/j.pnpbp.2017.02.021_bb0035","first-page":"CD008120","article-title":"Second-generation antipsychotics for anxiety disorders","volume":"8","author":"Depping","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"issue":"11","key":"10.1016\/j.pnpbp.2017.02.021_bb0040","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.euroneuro.2013.01.001","article-title":"Acute anxiolytic effects of quetiapine during virtual reality exposure - a double-blind placebo-controlled trial in patients with specific phobia","volume":"23","author":"Diemer","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2017.02.021_bb0045","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0304-3940(03)00647-5","article-title":"Brain activation to phobia-related pictures in spider phobic humans: an event-related functional magnetic resonance imaging study","volume":"348","author":"Dilger","year":"2003","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.pnpbp.2017.02.021_bb0050","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0165-1781(87)90002-3","article-title":"Measurement of lactate-induced panic and anxiety","volume":"20","author":"Dillon","year":"1987","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pnpbp.2017.02.021_bb0055","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00702-012-0811-1","article-title":"Revise the revised? New dimensions of the neuroanatomical hypothesis of panic disorder","volume":"120","author":"Dresler","year":"2013","journal-title":"J. Neural Transm."},{"issue":"10","key":"10.1016\/j.pnpbp.2017.02.021_bb0060","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1176\/appi.ajp.2007.07030504","article-title":"Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia","volume":"164","author":"Etkin","year":"2007","journal-title":"Am. J. Psychiatry"},{"issue":"9","key":"10.1016\/j.pnpbp.2017.02.021_bb0065","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.4088\/JCP.v67n0902","article-title":"Efficacy of typical and atypical antipsychotics for primary and comorbid anxiety symptoms or disorders: a review","volume":"67","author":"Gao","year":"2006","journal-title":"J. Clin. Psychiatry"},{"issue":"5","key":"10.1016\/j.pnpbp.2017.02.021_bb0070","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0893-133X(95)00147-6","article-title":"Symptoms essential to the experience of sodium lactate-induced panic","volume":"14","author":"Goetz","year":"1996","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.pnpbp.2017.02.021_bb0075","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/S0893-133X(02)00373-1","article-title":"Dextroamphetamine modulates the response of the human amygdala","volume":"27","author":"Hariri","year":"2002","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.pnpbp.2017.02.021_bb0080","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S0006-3223(02)01786-9","article-title":"Neocortical modulation of the amygdala response to fearful stimuli","volume":"53","author":"Hariri","year":"2003","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2017.02.021_bb0085","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/scan\/nsp013","article-title":"Emotion regulation in spider phobia: role of the medial prefrontal cortex","volume":"4","author":"Hermann","year":"2009","journal-title":"Soc. Cogn. Affect. Neurosci."},{"issue":"7","key":"10.1016\/j.pnpbp.2017.02.021_bb0090","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.tips.2004.05.009","article-title":"Human pharmacological MRI","volume":"25","author":"Honey","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"issue":"6","key":"10.1016\/j.pnpbp.2017.02.021_bb0095","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/archpsyc.62.6.617","article-title":"Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication","volume":"62","author":"Kessler","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"issue":"12","key":"10.1016\/j.pnpbp.2017.02.021_bb0100","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1111\/j.1360-0443.2011.03563.x","article-title":"Benzodiazepines revisited \u2013 will we ever learn?","volume":"106","author":"Lader","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.pnpbp.2017.02.021_bb0105","series-title":"Technical Report A-6","article-title":"International Affective Picture System (IAPS): Affective ratings of pictures and instruction manual","author":"Lang","year":"2005"},{"issue":"3","key":"10.1016\/j.pnpbp.2017.02.021_bb0110","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S1053-8119(03)00169-1","article-title":"An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets","volume":"19","author":"Maldjian","year":"2003","journal-title":"NeuroImage"},{"key":"10.1016\/j.pnpbp.2017.02.021_bb0115","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2147\/DDDT.S89485","article-title":"Quetiapine monotherapy in acute treatment of generalized anxiety disorder: a systematic review and meta-analysis of randomized controlled trials","volume":"10","author":"Maneeton","year":"2016","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.pnpbp.2017.02.021_bb0120","series-title":"Beck Angst-Inventar","author":"Margraf","year":"2007"},{"key":"10.1016\/j.pnpbp.2017.02.021_bb0125","series-title":"Profile of Mood States Manual (Rev.)","author":"McNair","year":"1992"},{"issue":"1","key":"10.1016\/j.pnpbp.2017.02.021_bb0130","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/YIC.0b013e32834d9f49","article-title":"Efficacy and tolerability of extended release quetiapine fumarate monotherapy in the acute treatment of generalized anxiety disorder: a randomized, placebo controlled and active-controlled study","volume":"27","author":"Merideth","year":"2012","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2017.02.021_bb0135","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1196\/annals.1401.006","article-title":"The role of the orbitofrontal cortex in anxiety disorders","volume":"1121","author":"Milad","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"4","key":"10.1016\/j.pnpbp.2017.02.021_bb0140","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.neuropsychologia.2010.10.004","article-title":"Modulating amygdala responses to emotion: evidence from pharmacological fMRI","volume":"49","author":"Patin","year":"2011","journal-title":"Neuropsychologia"},{"issue":"3","key":"10.1016\/j.pnpbp.2017.02.021_bb0145","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1001\/archpsyc.62.3.282","article-title":"Dose-dependent decrease of activation in bilateral amygdala and insula by lorazepam during emotion processing","volume":"62","author":"Paulus","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2017.02.021_bb0150","first-page":"214","article-title":"Quetiapine as combination treatment with citalopram in unipolar depression with prominent somatic symptoms: a randomised, double-blind, placebo-controlled pilot study","volume":"25","author":"Quante","year":"2013","journal-title":"Psychiatr. Danub."},{"issue":"1","key":"10.1016\/j.pnpbp.2017.02.021_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0005-7967(86)90143-9","article-title":"Anxiety sensitivity, anxiety frequency and the prediction of fearfulness","volume":"24","author":"Reiss","year":"1986","journal-title":"Behav. Res. Ther."},{"issue":"34","key":"10.1016\/j.pnpbp.2017.02.021_bb0160","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1192\/S0007125000293458","article-title":"Health economics and cost implications of anxiety and other mental disorders in the United States","author":"Rice","year":"1998","journal-title":"Br. J. Psychiatry Suppl."},{"issue":"2","key":"10.1016\/j.pnpbp.2017.02.021_bb0165","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1026\/0084-5345.31.2.110","article-title":"A questionnaire for the assessment of disgust sensitivity","volume":"31","author":"Schienle","year":"2002","journal-title":"Z. Klin. Psychol. Psychother."},{"issue":"1","key":"10.1016\/j.pnpbp.2017.02.021_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2005.06.025","article-title":"Brain activation of spider phobics towards disorder-relevant, generally disgust- and fear-inducing pictures","volume":"388","author":"Schienle","year":"2005","journal-title":"Neurosci. Lett."},{"issue":"4","key":"10.1016\/j.pnpbp.2017.02.021_bb0175","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1027\/1614-2241\/a000016","article-title":"Is it really robust? Reinvestigating the robustness of ANOVA against violations of assumptions of the normal distribution assumption","volume":"6","author":"Schmider","year":"2010","journal-title":"Methodology"},{"issue":"4","key":"10.1016\/j.pnpbp.2017.02.021_bb0180","doi-asserted-by":"crossref","first-page":"540","DOI":"10.4088\/JCP.v66n0420b","article-title":"Efficacy of quetiapine in generalized social anxiety disorder: results from an open-label study","volume":"66","author":"Schutters","year":"2005","journal-title":"J. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2017.02.021_bb0185","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.biopsych.2005.06.013","article-title":"Neural mechanisms of automatic and direct processing of phobogenic stimuli in specific phobia","volume":"59","author":"Straube","year":"2006","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2017.02.021_bb0190","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0005-7916(94)00072-T","article-title":"Fear of Spiders Questionnaire","volume":"26","author":"Szymanski","year":"1995","journal-title":"J. Behav. Ther. Exp. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.02.021_bb0195","series-title":"Using Multivariate Statistics","author":"Tabachnick","year":"2007"},{"issue":"4","key":"10.1016\/j.pnpbp.2017.02.021_bb0200","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.neuroimage.2005.05.039","article-title":"Effects of dopaminergic and serotonergic manipulation on emotional processing: a pharmacological fMRI study","volume":"27","author":"Takahashi","year":"2005","journal-title":"NeuroImage"},{"issue":"1","key":"10.1016\/j.pnpbp.2017.02.021_bb0205","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1006\/nimg.2001.0978","article-title":"Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain","volume":"15","author":"Tzourio-Mazoyer","year":"2002","journal-title":"NeuroImage"},{"issue":"7","key":"10.1016\/j.pnpbp.2017.02.021_bb0210","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.pnpbp.2007.06.027","article-title":"Quetiapine as monotherapy for social anxiety disorder: a placebo-controlled study","volume":"31","author":"Vaishnavi","year":"2007","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"9","key":"10.1016\/j.pnpbp.2017.02.021_bb0215","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.euroneuro.2011.07.018","article-title":"The size and burden of mental disorders and other disorders of the brain in Europe 2010","volume":"21","author":"Wittchen","year":"2011","journal-title":"Eur. Neuropsychopharmacol."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584616303463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584616303463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T02:28:03Z","timestamp":1568860083000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584616303463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":43,"alternative-id":["S0278584616303463"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2017.02.021","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of single-dose quetiapine on fear network activity \u2013 A pharmaco-imaging study","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2017.02.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}